Increasing the success rate of lantibiotic drug discovery by Synthetic Biology

Bibliography

• Baquero F, Coque TM, de la Cruz F. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother 2011;55(8):3649-60
   PubMed Web of Science ®Google Scholar
• Fernandez L, Breidenstein EBM, Hancock REW. Creeping baselines and adaptive resistance to antibiotics. Drug Resist Updat 2011;14(1):1-21
   PubMed Web of Science ®Google Scholar
• Rivera AM, Boucher HW. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc 2011;86(12):1230-43
   PubMed Web of Science ®Google Scholar
• Vos MC, Behrendt MD, Melles DC, 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009;30(10):977-84
   PubMed Web of Science ®Google Scholar
• Graveland H, Wagenaar JA, Heesterbeek H, Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS One 2010;5(6):e10990
   PubMed Web of Science ®Google Scholar
• Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet 2010;375(9725):1557-68
   PubMed Web of Science ®Google Scholar
• Harada K, Asai T. Role of antimicrobial selective pressure and secondary factors on antimicrobial resistance prevalence in Escherichia coli from food-producing animals in Japan. J Biomed Biotechnol 2010;2010:180682
   PubMedGoogle Scholar
• Burrowes B, Harper DR, Anderson J, Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther 2011;9(9):775-85
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, Bad Bugs, No Drugs: no ESKAPE! An Update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48(1):1-12
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control/European Medicines Agency Joint technical report. The bacterial challenge: time to react. 2009. DOI 10.2900/2518
   Google Scholar
• The Lancet. Urgently needed: new antibiotics. Lancet 2009;374(9705):1868-8
   Web of Science ®Google Scholar
• Spellberg B, Powers JH, Brass EP, Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004;38(9):1279-86
   PubMed Web of Science ®Google Scholar
• Willey JM, van der Donk WA. Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 2007;61:477-501
   PubMed Web of Science ®Google Scholar
• Lubelski J, Rink R, Khusainov R, Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci 2008;65(3):455-76
   PubMed Web of Science ®Google Scholar
• Bierbaum G, Sahl H-G. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 2009;10(1):2-18
   PubMed Web of Science ®Google Scholar
• Kuipers OP, Bierbaum G, Ottenwalder B, Protein engineering of lantibiotics. Antonie Van Leeuwenhoek 1996;69(2):161-9
   PubMed Web of Science ®Google Scholar
• Kuipers OP, Rollema HS, Yap WM, Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem 1992;267(34):24340-6
   PubMed Web of Science ®Google Scholar
• Chatterjee C, Paul M, Xie L, van der Donk WA. Biosynthesis and mode of action of lantibiotics. Chem Rev 2005;105(2):633-84
   PubMed Web of Science ®Google Scholar
• Velasquez JE, van der Donk WA. Genome mining for ribosomally synthesized natural products. Curr Opin Chem Biol 2011;15(1):11-21
   PubMed Web of Science ®Google Scholar
• Goto Y, Li B, Claesen J, Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol 2010;8(3):e1000339
   PubMed Web of Science ®Google Scholar
• Meindl K, Schmiederer T, Schneider K, Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl 2010;49(6):1151-4
   PubMed Web of Science ®Google Scholar
• Oman TJ, van der Donk WA. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol 2010;6(1):9-18
   PubMed Web of Science ®Google Scholar
• Kuipers A, de Boef E, Rink R, NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J Biol Chem 2004;279(21):22176-82
   PubMed Web of Science ®Google Scholar
• Rink R, Kluskens LD, Kuipers A, NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides. Biochemistry 2007;46(45):13179-89
   PubMed Web of Science ®Google Scholar
• Rink R, Wierenga J, Kuipers A, Production of dehydroamino acid-containing peptides by Lactococcus lactis. Appl Environ Microbiol 2007;73(6):1792-6
   PubMed Web of Science ®Google Scholar
• Chatterjee C, Patton GC, Cooper L, Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase. Chem Biol 2006;13(10):1109-17
   PubMed Web of Science ®Google Scholar
• Kluskens LD, Kuipers A, Rink R, Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry 2005;44(38):12827-34
   PubMed Web of Science ®Google Scholar
• Levengood MR, van der Donk WA. Use of lantibiotic synthetases for the preparation of bioactive constrained peptides. Bioorg Med Chem Lett 2008;18(10):3025-8
   PubMed Web of Science ®Google Scholar
• Breukink E, Wiedemann I, van Kraaij C, Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999;286(5448):2361-4
   PubMed Web of Science ®Google Scholar
• Hasper HE, Kramer NE, Smith JL, An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 2006;313(5793):1636-7
   PubMed Web of Science ®Google Scholar
• Pag U, Sahl H-G. Multiple activities in lantibiotics–models for the design of novel antibiotics? Curr Pharm Des 2002;8(9):815-33
   PubMed Web of Science ®Google Scholar
• Kramer NE, van Hijum SAFT, Knol J, Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob Agents Chemother 2006;50(5):1753-61
   PubMed Web of Science ®Google Scholar
• Jones T, Yeaman MR, Sakoulas G, Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 2008;52(1):269-78
   PubMed Web of Science ®Google Scholar
• Patel D, Husain M, Vidaillac C, Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. Int J Antimicrob Agents 2011;38(5):442-6
   PubMed Web of Science ®Google Scholar
• Draper LA, Grainger K, Deegan LH, Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol Microbiol 2009;71(4):1043-54
   PubMed Web of Science ®Google Scholar
• Mota-Meira M, LaPointe G, Lacroix C, Lavoie MC. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob Agents Chemother 2000;44(1):24-9
   PubMed Web of Science ®Google Scholar
• Piper C, Draper LA, Cotter PD, A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother 2009;64(3):546-51
   PubMed Web of Science ®Google Scholar
• van Heel AJ, Montalban-Lopez M, Kuipers OP. Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opin Drug Metab Toxicol 2011;7(6):675-80
   PubMed Web of Science ®Google Scholar
• Al-Mahrous MM, Upton M. Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application. Expert Opin Drug Discov 2011;6(2):155-70
   PubMed Web of Science ®Google Scholar
• Montalban-Lopez M, Sanchez-Hidalgo M, Valdivia E, Are bacteriocins underexploited? Novel applications for old antimicrobials. Curr Pharm Biotechnol 2011;12(8):1205-20
   PubMed Web of Science ®Google Scholar
• Rea MC, Sit CS, Clayton E, Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci USA 2010;107(20):9352-7
   PubMed Web of Science ®Google Scholar
• Xiao H, Chen X, Chen M, Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. Microbiology (Reading, Engl.) 2004;150(Pt 1):103-8
   PubMedGoogle Scholar
• Muller WM, Ensle P, Krawczyk B, Sussmuth RD. Leader peptide-directed processing of labyrinthopeptin A2 precursor peptide by the modifying enzyme LabKC. Biochemistry 2011;50(39):8362-73
   PubMed Web of Science ®Google Scholar
• Castiglione F, Cavaletti L, Losi D, A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry 2007;46(20):5884-95
   PubMed Web of Science ®Google Scholar
• Castiglione F, Lazzarini A, Carrano L, Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 2008;15(1):22-31
   PubMed Web of Science ®Google Scholar
• De La Fuente R, Sonawane ND, Arumainayagam D, Verkman AS. Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening. Br J Pharmacol 2006;149(5):551-9
   PubMed Web of Science ®Google Scholar
• Ymele-Leki P, Cao S, Sharp J, A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One 2012;7(2):e31307
   PubMed Web of Science ®Google Scholar
• Bosma T, Kuipers A, Bulten E, Bacterial display and screening of posttranslationally thioether-stabilized peptides. Appl Environ Microbiol 2011;77(19):6794-801
   PubMed Web of Science ®Google Scholar
• Ramon-Garcia S, Ng C, Anderson H, Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother 2011;55(8):3861-9
   PubMed Web of Science ®Google Scholar
• Stein T. Whole-cell matrix-assisted laser desorption/ionization mass spectrometry for rapid identification of bacteriocin/lantibiotic-producing bacteria. Rapid Commun Mass Spectrom 2008;22(8):1146-52
   PubMed Web of Science ®Google Scholar
• Hindre T, Didelot S, Le Pennec J-P, Bacteriocin detection from whole bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 2003;69(2):1051-8
   PubMed Web of Science ®Google Scholar
• Zendo T, Nakayama J, Fujita K, Sonomoto K. Bacteriocin detection by liquid chromatography/mass spectrometry for rapid identification. J Appl Microbiol 2008;104(2):499-507
   PubMed Web of Science ®Google Scholar
• Rose Sporns. McMullen. detection of bacteriocins by matrix-assisted laser Desorption/Ionization time-of-flight mass spectrometry. Appl Environ Microbiol 1999;65(5):2238-42
   PubMed Web of Science ®Google Scholar
• Kersten RD, Yang Y-L, Xu Y, A mass spectrometry–guided genome mining approach for natural product peptidogenomics. Nat Chem Biol 2011;7(11):794-802
   PubMed Web of Science ®Google Scholar
• Deegan LH, Suda S, Lawton EM, Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol 2010;3(2):222-34
   PubMedGoogle Scholar
• Ross AC, Vederas JC. Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides. J Antibiot 2011;64(1):27-34
   PubMed Web of Science ®Google Scholar
• Field D, Collins B, Cotter PD, A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities. J Mol Microbiol Biotechnol 2007;13(4):226-34
   PubMed Web of Science ®Google Scholar
• You YO, van der Donk WA. Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis. Biochemistry 2007;46(20):5991-6000
   PubMed Web of Science ®Google Scholar
• Cotter PD, Deegan LH, Lawton EM, Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 2006;62(3):735-47
   PubMed Web of Science ®Google Scholar
• Rink R, Wierenga J, Kuipers A, Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol 2007;73(18):5809-16
   PubMed Web of Science ®Google Scholar
• Islam MR, Nishie M, Nagao J-I, Ring A of Nukacin ISK-1: A Lipid II-Binding Motif for Type-A(II) Lantibiotic. J Am Chem Soc. 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22329487. [Accedido febrero 28, 2012]
   Google Scholar
• van der Meer JR, Rollema HS, Siezen RJ, Influence of amino acid substitutions in the nisin leader peptide on biosynthesis and secretion of nisin by Lactococcus lactis. J Biol Chem 1994;269(5):3555-62
   PubMed Web of Science ®Google Scholar
• Plat A, Kluskens LD, Kuipers A, Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage. Appl Environ Microbiol 2011;77(2):604-11
   PubMed Web of Science ®Google Scholar
• Rollema HS, Kuipers OP, Both P, Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol 1995;61(8):2873-8
   PubMed Web of Science ®Google Scholar
• Field D, Connor PMO, Cotter PD, The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol 2008;69(1):218-30
   PubMed Web of Science ®Google Scholar
• Rouse S, Field D, Daly KM, Bioengineered nisin derivatives with enhanced activity in complex matrices. Microbial Biotechnol 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22260415. [Accedido febrero 28, 2012]
   Google Scholar
• Velasquez JE, van der Donk WA. Genome mining for ribosomally synthesized natural products. Curr Opin Chem Biol 2011;15(1):11-21
   PubMed Web of Science ®Google Scholar
• McClerren AL, Cooper LE, Quan C, Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci USA 2006;103(46):17243-8
   PubMed Web of Science ®Google Scholar
• Lawton EM, Cotter PD, Hill C, Ross RP. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol. Lett 2007;267(1):64-71
   PubMed Web of Science ®Google Scholar
• Dischinger J, Josten M, Szekat C, Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One 2009;4(8):e6788
   PubMed Web of Science ®Google Scholar
• Begley M, Cotter PD, Hill C, Ross RP. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol 2009;75(17):5451-60
   PubMed Web of Science ®Google Scholar
• de Jong A, van Heel AJ, Kok J, Kuipers OP. BAGEL2: mining for bacteriocins in genomic data. Nucleic Acids Res 2010;38(Web Server issue):W647-51
   PubMedGoogle Scholar
• de Jong A, van Hijum SAFT, Bijlsma JJE, BAGEL: a web-based bacteriocin genome mining tool. Nucleic Acids Res 2006;34(Web Server issue):W273-9
   PubMedGoogle Scholar
• Hammami R, Zouhir A, Le Lay C, BACTIBASE second release: a database and tool platform for bacteriocin characterization. BMC Microbiol 2010;10:22
   PubMed Web of Science ®Google Scholar
• Li B, Sher D, Kelly L, Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc Natl Acad Sci USA 2010;107(23):10430-5
   PubMed Web of Science ®Google Scholar
• Wang H, Fewer DP, Sivonen K. Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria. PLoS ONE. 2011;6(7):e22384
   Google Scholar
• Daly KM, Upton M, Sandiford SK, Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol 2010;192(4):1131-42
   PubMed Web of Science ®Google Scholar
• Marsh AJ, O’Sullivan O, Ross RP, In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics 2010;11(1):679
   PubMed Web of Science ®Google Scholar
• Nandagopal N, Elowitz MB. Synthetic biology: integrated gene circuits. Science 2011;333(6047):1244-8
   PubMed Web of Science ®Google Scholar
• Majchrzykiewicz JA, Lubelski J, Moll GN, Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence. Antimicrob Agents Chemother 2010;54(4):1498-505
   PubMed Web of Science ®Google Scholar
• Caetano T, Krawczyk JM, Mosker E, Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol 2011;18(1):90-100
   PubMed Web of Science ®Google Scholar
• Shi Y, Yang X, Garg N, van der Donk WA. Production of lantipeptides in Escherichia coli. J Am Chem Soc 2011;133(8):2338-41
   PubMed Web of Science ®Google Scholar
• Nagao J-I, Harada Y, Shioya K, Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Biochem Biophys Res Commun 2005;336(2):507-13
   PubMed Web of Science ®Google Scholar
• Oldach F, Al Toma R, Kuthning A, Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew Chem Int Ed Engl 2011. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22128014. [Accedido febrero 26, 2012]
   Google Scholar
• Huisgen R, Grashey R, Sauer J. Chemistry of alkenes. Interscience; En: New York: 1964. p. 806-77
   Google Scholar
• Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angewandte Chemie Int Ed 2001;40(11):2004-21
   PubMed Web of Science ®Google Scholar
• Chiang Y-M, Chang S-L, Oakley BR, Wang CCC. Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms. Curr Opin Chem Biol 2011;15(1):137-43
   PubMed Web of Science ®Google Scholar
• Asaduzzaman SM, Sonomoto K. Lantibiotics: diverse activities and unique modes of action. J Biosci Bioeng 2009;107(5):475-87
   PubMed Web of Science ®Google Scholar
• Kupke T, Kempter C, Jung G, Gotz F. Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem 1995;270(19):11282-9
   PubMed Web of Science ®Google Scholar
• Suda S, Cotter PD, Hill C, Ross RP. Lacticin 3147 - biosynthesis, molecular analysis, immunity, bioengineering and applications. Curr Protein Pept Sci 2011. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21827422. [Accedido febrero 28, 2012]
   Google Scholar
• Mammen M, Choi S, Whitesides GM. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angewandte Chemie Int Ed 1998;37(20):2754-94
   PubMed Web of Science ®Google Scholar
• Arnusch CJ, Bonvin AMJJ, Verel AM, The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci. Biochemistry 2008;47(48):12661-3
   PubMed Web of Science ®Google Scholar
• Tabor AB. The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides. Org Biomol Chem 2011;9(22):7606-28
   PubMed Web of Science ®Google Scholar
• Levengood MR, Knerr PJ, Oman TJ, van der Donk WA. In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids. J Am Chem Soc 2009;131(34):12024-5
   PubMed Web of Science ®Google Scholar
• Levengood MR, Kerwood CC, Chatterjee C, van der Donk WA. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids. Chembiochem 2009;10(5):911-19
   PubMed Web of Science ®Google Scholar
• Zhang X, Ni W, van der Donk WA. On the regioselectivity of thioether formation by lacticin 481 synthetase. Org Lett 2007;9(17):3343-6
   PubMed Web of Science ®Google Scholar
• Zhang X, van der Donk WA. On the substrate specificity of dehydration by lacticin 481 synthetase. J Am Chem Soc 2007;129(8):2212-13
   PubMed Web of Science ®Google Scholar
• Goto Y, Iwasaki K, Torikai K, Ribosomal synthesis of dehydrobutyrine- and methyllanthionine-containing peptides. Chem Commun (Camb.) 2009(23):3419-21
   PubMed Web of Science ®Google Scholar
• Seebeck FP, Ricardo A, Szostak JW. Artificial lantipeptides from in vitro translations. Chem Commun (Camb.) 2011;47(21):6141-3
   PubMed Web of Science ®Google Scholar
• Mothia B, Appleyard AN, Wadman S, Tabor AB. Synthesis of peptides containing overlapping lanthionine bridges on the solid phase: an analogue of rings D and E of the lantibiotic nisin. Org Lett 2011;13(16):4216-19
   PubMed Web of Science ®Google Scholar
• Liu W, Chan ASH, Liu H, Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147. J Am Chem Soc 2011;133(36):14216-19
   PubMed Web of Science ®Google Scholar
• Pattabiraman VR, Stymiest JL, Derksen DJ, Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2. Org Lett 2007;9(4):699-702
   PubMed Web of Science ®Google Scholar
• Harmsen RAG, Ghalit N, Kemmink J, Alkene/alkane-bridged mimics of the lantibiotic nisin: toward novel peptide-based antibiotics. Adv Exp Med Biol 2009;611:533-4
   PubMed Web of Science ®Google Scholar
• Liu H, Pattabiraman VR, Vederas JC. Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen. Org Lett 2009;11(24):5574-7
   PubMed Web of Science ®Google Scholar
• Papo N, Oren Z, Pag U, The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J Biol Chem 2002;277(37):33913-21
   PubMed Web of Science ®Google Scholar
• Okesli A, Cooper LE, Fogle EJ, van der Donk WA. Nine post-translational modifications during the biosynthesis of cinnamycin. J Am Chem Soc 2011;133(34):13753-60
   PubMed Web of Science ®Google Scholar
• Meyer HE, Heber M, Eisermann B, Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal Biochem 1994;223(2):185-90
   PubMed Web of Science ®Google Scholar
• Mørtvedt CI, Nissen-Meyer J, Sletten K, Nes IF. Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl Environ Microbiol 1991;57(6):1829-34
   PubMed Web of Science ®Google Scholar
• van de Kamp M, Horstink LM, van den Hooven HW, Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur J Biochem 1995;227(3):757-71
   PubMedGoogle Scholar
• Majer F, Schmid DG, Altena K, The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol 2002;184(5):1234-43
   PubMed Web of Science ®Google Scholar
• Foulston LC, Bibb MJ. Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes. Proc Natl Acad Sci USA 2010;107(30):13461-6
   PubMed Web of Science ®Google Scholar
• Boakes S, Cortes J, Appleyard AN, Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system. Mol Microbiol 2009;72(5):1126-36
   PubMed Web of Science ®Google Scholar
• He Z, Yuan C, Zhang L, Yousef AE. N-terminal acetylation in paenibacillin, a novel lantibiotic. FEBS Lett 2008;582(18):2787-92
   PubMed Web of Science ®Google Scholar